The successful treatment of mpox with brincidofovir in renal transplant recipients-a report of 2 cases

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved..

An mpox outbreak was declared in July 2022 by the world health organization (WHO). It causes a mild self-limiting disease however; in immunosuppressed hosts, it tends to cause severe disseminated infection. Most cases of mpox in sold organ transplant (SOT) recipients reported in the literature were treated with tecovirimat. Here we report two cases of severe disseminated mpox infection in renal transplant recipients that were successfully treated with brincidofovir. Both patients were discharged from the hospital with no immediate significant side effects from brincidofovir reported until the submission of this report.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:143

Enthalten in:

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases - 143(2024) vom: 21. März, Seite 107015

Sprache:

Englisch

Beteiligte Personen:

Alameer, Reem M [VerfasserIn]
Yamani, Amani [VerfasserIn]
Al-Saud, Abdulrahman [VerfasserIn]
Alsobayeg, Sultan [VerfasserIn]
Alamro, Bayan [VerfasserIn]
Alali, Alaa [VerfasserIn]
Hammad, Ehab [VerfasserIn]
Shendi, Ali M [VerfasserIn]
Almaghrabi, Reem S [VerfasserIn]

Links:

Volltext

Themen:

Brincidofovir
Case Reports
Kidney transplant
Monkeypox virus
Mpox
Renal transplant
Solid organ transplant

Anmerkungen:

Date Revised 22.04.2024

published: Print-Electronic

Citation Status Publisher

doi:

10.1016/j.ijid.2024.107015

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM370110137